Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 786

1.

Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.

Stensland MD, Jacobson JG, Nyhuis A.

J Affect Disord. 2007 Aug;101(1-3):187-93. Epub 2007 Jan 23.

PMID:
17254637
2.

Costs associated with attempted suicide among individuals with bipolar disorder.

Stensland MD, Zhu B, Ascher-Svanum H, Ball DE.

J Ment Health Policy Econ. 2010 Jun;13(2):87-92.

PMID:
20919595
3.

The impact of treatment-resistant depression on health care utilization and costs.

Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM.

J Clin Psychiatry. 2002 Nov;63(11):963-71.

PMID:
12444808
4.

Health care utilization and costs among privately insured patients with bipolar I disorder.

Bryant-Comstock L, Stender M, Devercelli G.

Bipolar Disord. 2002 Dec;4(6):398-405.

PMID:
12519100
5.

Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis.

Stensland MD, Schultz JF, Frytak JR.

J Clin Psychiatry. 2008 May;69(5):749-58.

PMID:
18363423
6.
7.

Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs.

Matza LS, Rajagopalan KS, Thompson CL, de Lissovoy G.

J Clin Psychiatry. 2005 Nov;66(11):1432-40.

PMID:
16420081
8.

Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.

Harley C, Li H, Corey-Lisle P, L'Italien GJ, Carson W.

Soc Psychiatry Psychiatr Epidemiol. 2007 Sep;42(9):690-7. Epub 2007 Jun 29.

PMID:
17603740
9.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
10.

Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses.

Stensland MD, Schultz JF, Frytak JR.

BMC Psychiatry. 2010 Jun 4;10:39. doi: 10.1186/1471-244X-10-39.

11.

Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.

Birnbaum HG, Shi L, Dial E, Oster EF, Greenberg PE, Mallett DA.

J Clin Psychiatry. 2003 Oct;64(10):1201-9.

PMID:
14658969
12.

Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis.

Stender M, Bryant-Comstock L, Phillips S.

Clin Ther. 2002 Oct;24(10):1668-76.

PMID:
12462295
13.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
14.

Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees.

Hankin CS, Koran L, Sheehan DV, Hollander E, Culpepper L, Black DW, Knispel J, Dunn J, Dougherty DD, Bronstone A, Wang Z.

Ann Clin Psychiatry. 2011 Nov;23(4):285-96.

PMID:
22073386
15.

Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.

Revicki DA, Hirschfeld RM, Ahearn EP, Weisler RH, Palmer C, Keck PE Jr.

J Affect Disord. 2005 Jun;86(2-3):183-93.

PMID:
15935238
16.

Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.

Bagalman E, Muser E, Choi JC, Durden E, Macfadden W, Haskins JT, Dirani R.

Clin Ther. 2011 Oct;33(10):1381-1390.e4. doi: 10.1016/j.clinthera.2011.09.005. Epub 2011 Oct 14. Erratum in: Clin Ther. 2011 Dec;33(12):2093.

PMID:
22000656
17.

Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.

Williams MD, Shah ND, Wagie AE, Wood DL, Frye MA.

Psychiatr Serv. 2011 Sep;62(9):1073-8. doi: 10.1176/appi.ps.62.9.1073.

PMID:
21885587
18.

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H.

Curr Med Res Opin. 2007 Nov;23(11):2805-14.

PMID:
17910804
19.

Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.

Baldessarini R, Henk H, Sklar A, Chang J, Leahy L.

Psychiatr Serv. 2008 Oct;59(10):1175-83. doi: 10.1176/appi.ps.59.10.1175.

PMID:
18832504
20.

The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.

Asche CV, Joish VN, Camacho F, Drake CL.

Curr Med Res Opin. 2010 Aug;26(8):1843-53. doi: 10.1185/03007995.2010.488037.

PMID:
20515321
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk